J&J | JNJ - Umlaufvermögen





Umlaufvermögen Veränderung Datum
AbbVie USD 33.53B 4.47B 2026-03
Abbott USD 25.51B 488M 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Baxter International USD 6.85B 25M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Biogen USD 9.19B 216.3M 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
CONMED USD 670.59M 2.27M 2026-03
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.33B 298.4M 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Globus Medical USD 2.2B 72.51M 2026-03
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.17B 12.47M 2026-03
Intuitive Surgical USD 11.52B 881.5M 2026-03
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merck USD 35.02B 8.5B 2026-03
Merit Medical Systems USD 1.1B 61.62M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Stryker USD 13.34B 1.42B 2026-03
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03
Zoetis USD 6.47B 294M 2026-03